RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker.
Linglong TaoXiaoyu XuZhengxuying FangPetros ChristopoulosDiego CortinovisYi LuPublished in: Translational cancer research (2024)
can serve as both as an immunotherapy target and as a diagnostic and prognostic biomarker.